Company Valuation: TELCON RF PHARMACEUTICAL. Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 517,387 255,964 110,233 97,672 70,587 62,827
Change - -50.53% -56.93% -11.39% -27.73% -10.99%
Enterprise Value (EV) 1 580,973 288,705 130,775 114,577 116,241 64,971
Change - -50.31% -54.7% -12.39% 1.45% -44.11%
P/E -12x -11.1x -2.56x 8.52x -2.64x -3.84x
PBR 5.81x 2.74x 1.31x 0.97x 0.85x 0.58x
PEG - 0.2x -0.1x -0x 0x 0.1x
Capitalization / Revenue 15.6x 6.76x 3.96x 2.69x 1.86x 1.46x
EV / Revenue 17.5x 7.63x 4.7x 3.16x 3.07x 1.51x
EV / EBITDA 252x -795x 599x 22x 26.2x 11.7x
EV / EBIT -278x -63.3x -32.2x 119x -1,648x 90.4x
EV / FCF -562x -37.4x 414x -21.5x 11.2x -7.31x
FCF Yield -0.18% -2.67% 0.24% -4.64% 8.9% -13.7%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -16,772 -8,764 -13,233 3,417 -7,417 -2,390
Distribution rate - - - - - -
Net sales 1 33,141 37,841 27,830 36,307 37,865 43,162
EBITDA 1 2,307 -363.1 218.5 5,210 4,436 5,543
EBIT 1 -2,090 -4,563 -4,063 965.3 -70.55 718.6
Net income 1 -40,893 -23,098 -42,084 13,906 -26,320 -11,456
Net Debt 1 63,586 32,741 20,542 16,904 45,654 2,143
Reference price 2 202,000.00 97,500.00 33,833.33 29,100.00 19,566.67 9,170.00
Nbr of stocks (in thousands) 2,561 2,625 3,258 3,356 3,608 6,851
Announcement Date 3/22/21 3/22/22 3/21/23 3/19/24 3/18/25 3/19/26
1KRW in Million2KRW
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 10.82M
34.34x7.19x18.57x1.48% 440B
50.87x18.02x36.16x-.--% 244B
22.32x0.9x16.02x2.08% 195B
34.74x10.97x27x0.32% 172B
176.81x26.23x76.9x-.--% 78.34B
34.05x6.59x18.81x0.99% 77.7B
77.91x9.08x41.9x-.--% 57.41B
42.55x2.25x14.63x1.69% 57.69B
29.71x6.73x22.52x1.39% 57.36B
Average 55.92x 9.77x 30.28x 0.88% 137.88B
Weighted average by Cap. 45.66x 9.59x 26.67x 0.99%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. A200230 Stock
  4. Valuation TELCON RF PHARMACEUTICAL. Inc.